Rachel Humphrey - Aug 11, 2022 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Rachel Humphrey
Stock symbol
PYXS
Transactions as of
Aug 11, 2022
Transactions value $
$0
Form type
4
Date filed
8/15/2022, 05:44 PM
Previous filing
Oct 21, 2021
Next filing
Mar 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $0 +236K $0.00 236K Aug 11, 2022 Common Stock 236K $2.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in three equal annual installments from the grant date, subject to the reporting person's continued service through the applicable vesting date.